Main investor Thomas Strungmann wants to turn the vaccine developer into an “independent, fully integrated pharmaceutical company from Germany”. He rules out a sale in the long term. After the…
Read More
The European Medicines Agency (EMA) has approved the use of the Covid-19 vaccine developed jointly by the US company Pfizer a nd its German partner BioNTech, putting Europe on track…
Read More
Berlin – Istanbul-Pfizer and Biontech are making progress in their search for a vaccine against the Sars Cov-2 virus. Further data from an early phase we study with the drug…
Read MorePage 1 of 1